Impotence-free hormonal treatment of prostate cancer.
Since the protein-specific antigen (PSA) test is systematically used in some countries for cancer detection, many asymptomatic and latent cancer patients are uselessly victims of anxiety, hormonotherapy, and impotence, when they are not demolished by surgery and/or radiotherapy's local and/or regional complications. We propose to conduct a study of dexamethasone as treatment of such latent, small and even wrongly diagnosed cases. Certainly it exerts at small doses a discrete hormonal effect. But it has an anti-growth factor effect, which may explain its often beneficial action on prostate cancer with resistance to androgen inhibitors.
Mathé
G
G
D000368:Aged; D003907:Dexamethasone / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000209:etiology*; D006801:Humans; D007049:Iatrogenic Disease / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D003907:Dexamethasone; D017430:Prostate-Specific Antigen